Header Logo

Connection

AHMED ELKHANANY to Pyrrolidines

Back to Details
This is a "connection" page, showing publications AHMED ELKHANANY has written about Pyrrolidines.
AHMED ELKHANANY
Connection Strength
0.050
Pyrrolidines
  1. Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. Ann Oncol. 2023 12; 34(12):1131-1140.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.